Quest Diagnostics Incorporated Stock Buy Hold or Sell Recommendation
| DGX Stock | USD 163.59 0.30 0.18% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Quest Diagnostics Incorporated is 'Strong Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Quest Diagnostics Incorporated given historical horizon and risk tolerance towards Quest Diagnostics. When Macroaxis issues a 'buy' or 'sell' recommendation for Quest Diagnostics Incorporated, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Quest Diagnostics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Quest and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Quest Diagnostics Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Quest |
Execute Quest Diagnostics Buy or Sell Advice
The Quest recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Quest Diagnostics Incorporated. Macroaxis does not own or have any residual interests in Quest Diagnostics Incorporated or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Quest Diagnostics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Quest Diagnostics Trading Alerts and Improvement Suggestions
| Quest Diagnostics has a strong financial position based on the latest SEC filings | |
| Over 92.0% of the company shares are held by institutions such as insurance companies | |
| On 21st of October 2024 Quest Diagnostics paid $ 0.75 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: 6.1 Bn Dietary Supplement Testing Services Global Market Opportunities and Strategies to 2033 Contaminant Testing Platforms, Adulteration Panel Analysis, AI-Driven Platforms for Improved Testing |
Quest Diagnostics Returns Distribution Density
The distribution of Quest Diagnostics' historical returns is an attempt to chart the uncertainty of Quest Diagnostics' future price movements. The chart of the probability distribution of Quest Diagnostics daily returns describes the distribution of returns around its average expected value. We use Quest Diagnostics Incorporated price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Quest Diagnostics returns is essential to provide solid investment advice for Quest Diagnostics.
| Mean Return | 0.12 | Value At Risk | -1.77 | Potential Upside | 1.59 | Standard Deviation | 1.25 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Quest Diagnostics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Quest Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Quest Diagnostics, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Quest Diagnostics Incorporated back and forth among themselves.
| Shares | Amvescap Plc. | 2024-06-30 | 1.8 M | Goldman Sachs Group Inc | 2024-06-30 | 1.7 M | Jpmorgan Chase & Co | 2024-06-30 | 1.5 M | Wells Fargo & Co | 2024-06-30 | 1.5 M | Fiduciary Management, Inc. Of Milwaukee | 2024-09-30 | 1.4 M | Norges Bank | 2024-06-30 | 1.3 M | Fmr Inc | 2024-09-30 | 1.1 M | Northern Trust Corp | 2024-09-30 | 1 M | Legal & General Group Plc | 2024-06-30 | 959.6 K | Vanguard Group Inc | 2024-09-30 | 14 M | Blackrock Inc | 2024-06-30 | 10.1 M |
Quest Diagnostics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 1.1B | (34M) | (286M) | (557M) | 371M | 389.6M | |
| Free Cash Flow | 843M | 1.6B | 1.8B | 1.3B | 864M | 719.7M | |
| Depreciation | 329M | 361M | 408M | 437M | 439M | 264.3M | |
| Other Non Cash Items | (98M) | (59M) | (364M) | 69M | 100M | 151.5M | |
| Dividends Paid | 286M | 297M | 309M | 305M | 314M | 329.7M | |
| Capital Expenditures | 400M | 418M | 403M | 404M | 408M | 289.1M | |
| Net Income | 906M | 1.5B | 2.1B | 1.0B | 850M | 646.8M | |
| End Period Cash Flow | 1.2B | 1.2B | 872M | 315M | 686M | 720.3M | |
| Change To Netincome | (27M) | 123M | (257M) | 147M | 169.1M | 164.9M | |
| Change To Inventory | 16M | 4M | 29M | (20M) | (23M) | (21.9M) | |
| Net Borrowings | 124M | 832M | (805M) | (2M) | (1.8M) | (1.7M) | |
| Investments | (411M) | (772M) | 752M | (543M) | (1.1B) | (1.1B) | |
| Change Receivables | (63M) | (455M) | 81M | 246M | 282.9M | 297.0M |
Quest Diagnostics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Quest Diagnostics or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Quest Diagnostics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Quest stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.06 | |
β | Beta against Dow Jones | 0.43 | |
σ | Overall volatility | 1.27 | |
Ir | Information ratio | -0.01 |
Quest Diagnostics Volatility Alert
Quest Diagnostics Incorporated has relatively low volatility with skewness of 2.17 and kurtosis of 12.13. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Quest Diagnostics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Quest Diagnostics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Quest Diagnostics Fundamentals Vs Peers
Comparing Quest Diagnostics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Quest Diagnostics' direct or indirect competition across all of the common fundamentals between Quest Diagnostics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Quest Diagnostics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Quest Diagnostics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Quest Diagnostics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Quest Diagnostics to competition |
| Fundamentals | Quest Diagnostics | Peer Average |
| Return On Equity | 0.13 | -0.31 |
| Return On Asset | 0.0566 | -0.14 |
| Profit Margin | 0.09 % | (1.27) % |
| Operating Margin | 0.14 % | (5.51) % |
| Current Valuation | 24.47 B | 16.62 B |
| Shares Outstanding | 111.61 M | 571.82 M |
| Shares Owned By Insiders | 0.43 % | 10.09 % |
| Shares Owned By Institutions | 91.58 % | 39.21 % |
| Number Of Shares Shorted | 2.38 M | 4.71 M |
| Price To Earning | 14.57 X | 28.72 X |
| Price To Book | 2.68 X | 9.51 X |
| Price To Sales | 1.91 X | 11.42 X |
| Revenue | 9.25 B | 9.43 B |
| Gross Profit | 3.47 B | 27.38 B |
| EBITDA | 1.26 B | 3.9 B |
| Net Income | 850 M | 570.98 M |
| Cash And Equivalents | 315 M | 2.7 B |
| Cash Per Share | 6.15 X | 5.01 X |
| Total Debt | 5.37 B | 5.32 B |
| Debt To Equity | 0.73 % | 48.70 % |
| Current Ratio | 1.46 X | 2.16 X |
| Book Value Per Share | 60.80 X | 1.93 K |
| Cash Flow From Operations | 1.27 B | 971.22 M |
| Short Ratio | 3.02 X | 4.00 X |
| Earnings Per Share | 7.44 X | 3.12 X |
| Price To Earnings To Growth | 1.91 X | 4.89 X |
| Target Price | 167.36 | |
| Number Of Employees | 50 K | 18.84 K |
| Beta | 0.89 | -0.15 |
| Market Capitalization | 18.26 B | 19.03 B |
| Total Asset | 14.02 B | 29.47 B |
| Retained Earnings | 8.82 B | 9.33 B |
| Working Capital | 557 M | 1.48 B |
Note: Disposition of 1775 shares by Karthik Kuppusamy of Quest Diagnostics at 156.9156 subject to Rule 16b-3 [view details]
Quest Diagnostics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Quest . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Quest Diagnostics Buy or Sell Advice
When is the right time to buy or sell Quest Diagnostics Incorporated? Buying financial instruments such as Quest Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Quest Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Government Funds Thematic Idea Now
Government Funds
Funds or Etfs that invest in fixed income securities issued by national government to finance government spending or to facilitate Federal Reserve monetary policies. The Government Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Government Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Quest Stock Analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.